Skip to main content
. 2020 Feb 10;11(2):87–96. doi: 10.1007/s12672-020-00380-8

Table 1.

Correlated MMP-9 expression to PELP1 in ER-positive breast cancer tissues

Immunoactivity of PELP1 Immunoactivity of MMP-9 r P
Negative (n = 27) Weak (n = 25) Moderate (n = 28) Strong (n = 29)
Negative (n = 19) 8 (42.1%) 6 (31.6%) 2 (10.5%) 3 (15.8%) 0.293 0.002
Moderate (n = 44) 12 (27.3%) 10 (22.7%) 14 (31.8%) 8 (18.2%)
Strong (n = 46) 7 (15.2%) 9 (19.6%) 12 (26.1%) 18 (39.1%)